Glaucoma Treatment Market 2014-2019 Global Trends & Opportunities Reviewed in New Research Report

DALLAS, September 30, 2014 /PRNewswire/ --

MarketReportsOnline.com adds Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019) research report that provides an insight into the glaucoma treatment market over the years with a special focus on major categories- pharmaceuticals and devices. The report includes detailed information on market size and share by type of drugs in glaucoma treatment sector. It also discusses key growth drivers, challenges and trends of the market. Complete report is available at http://www.marketreportsonline.com/357921.html .

This glaucoma treatment market report covers provides data and information on The US and Japan under its country coverage. Glaucoma treatment forms a significant portion of the overall eye care market. The market for glaucoma treatment has grown rapidly in the last decade, based on both increasing number of people with glaucoma and the introduction of new treatments. However, the worldwide glaucoma treatment market is expected to decline that can be attributable to price reduction of drugs due to generic availability of many brands in coming years. Companies like Pfizer Inc, Merck & Co, Allergan Inc and Alcon (Division of Novartis) are profiled in the report, available for purchase at http://www.marketreportsonline.com/contacts/purchase.php?name=357921 .

For this glaucoma treatment market research, the glaucoma pharmaceuticals are segmented into two classes namely prostaglandins analogues (PGAs) and Non PGAs that include beta blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are the most widely prescribed drug class for glaucoma with latanoprost (brand name Xalatan) the most commonly prescribed drug.

Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented. Leaders in glaucoma medication space include Pfizer Inc, Alcon Inc. (Novartis), Allergan Inc and Merck and Co, Inc. Companies developing glaucoma drug-delivery devices include Ocular Therapeutix Inc, QLT Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC, Euclid Systems Corp and Replenish Inc. In glaucoma laser market, top market leaders include Ellex, Lumenis, Quantel and Lightmed.

List of Figures provided in Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019) research report includes:

Figure 1: Diagram of the Structure of the Eye (left) and Damage from Glaucoma (Right)    

Figure 2: Global Eye Care Market Size in US$ Billion, 2013-2018F    

Figure 3: Global Eye Care Market Segmentation in %, 2013    

Figure 4: Breakup of Global Eye Surgical Market in US$ Billion, 2013    

Figure 5: Breakup of Global Ophthalmic Pharmaceuticals Market in US$ Billion, 2013    

Figure 6: Breakup of Global Vision Care Industry in US$ Billion, 2013    

Figure 7: Global Glaucoma Treatment Market Sales in US$ Billion, 2010-2013    

Figure 8: Total Worldwide Glaucoma Market Annual Prescriptions in Million, 2012-2019F    

Figure 9: Forecast Global Glaucoma Treatment Market in US$ Billion, 2014F-2019F

Figure 10: Market Share of Commonly Prescribed Glaucoma Drugs in %, 2013

Figure 11: Global Glaucoma Devices Market Size in US$ Million, 2008-2013    

Figure 12: Global Glaucoma Devices Market Segmentation in %, 2013    

Figure 13: The US Glaucoma Market Sales in US$ Billion, 2012-2020F    

Figure 14: The US Glaucoma Market Annual Prescriptions in Million, 2012-2020F

Figure 15: The US Glaucoma Market Composition in %, 2013    

Figure 16: The US Prostaglandin Market Sales and Annual Prescriptions, 2012-2020F    

Figure 17: The US Beta Blocker Market Sales and Annual Prescriptions, 2012-2020F

Figure 18: The US Combination Glaucoma Market Sales and Annual Prescriptions, 2012-2020F    

Figure 19: The US Carbonic Anhydrase Market Sales and Annual Prescriptions, 2012-2020F    

Figure 20: Japan Prescription Ophthalmic Pharmaceuticals Market in US$ Billion, 2009-2013    

Figure 21: Japan Prescription Ophthalmic Pharmaceuticals Market Segmentation in %, 2013    

Figure 22: Japan Glaucoma Treatment Market in US$ Million, 2012-2013    

Figure 23: Global Total Population ages 65 and above in Million, 2007-2013    

Figure 24: Global Healthcare Expenditures Per Capita in US$, 2007-2013    

Figure 25: Share of Monotherapies and Combinations Glaucoma Drugs in %, 2013 versus 2018F    

Figure 26: Shares of Global Ophthalmic Laser Market Players in %, 2013    

Figure 27: Pfizer's Revenue Share by Business Segments in %, 2013    

Figure 28: Pfizer - Revenues from Xalatan/Xalacom in US$ Million, 2011-2013

Figure 29: Merck & Co., Inc. Revenue by Business Segment in %, 2013    

Figure 30: Merck & Co., Inc - Revenue from Cosopt/Trusopt in US$ Million, 2011-2013    

Figure 31: Allergan Inc Business Segmentation by Revenue in %, 2013    

Figure 32: Allergan - Revenue from Total Glaucoma Products in US$ Million, 2011-2013    

Figure 33: Revenue from Alcon Division in US$ Million, 2011-2013    

On similar lines, Glaucoma Partnering 2009-2014 is on-demand market research reports that can be delivered within 3-4 working days post its purchase. This report provides understanding and access to the glaucoma partnering deals and agreements entered into by the world's leading healthcare companies covering Trends in glaucoma partnering deals, Top glaucoma deals by value and Deals listed by company A-Z, industry sector, stage of development, technology type. This data driven report contains over 30 links to online copies of actual liver disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Read more at http://www.marketreportsonline.com/223661.html .

Explore more healthcare market reports as well as other research studies on Pharmaceuticals industry at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us: 

MarketReportsOnline.com is an online market research reports library of 300,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact: 

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
sales@marketreportsonline.com